Decoding endocannabinoid signaling
- 1 January 2009
- journal article
- Published by Springer Science and Business Media LLC in Nature Chemical Biology
- Vol. 5 (1), 8-9
- https://doi.org/10.1038/nchembio0109-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effectsNature Chemical Biology, 2008
- The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 productsPharmacology & Therapeutics, 2008
- CANNABINOID RECEPTORS AS THERAPEUTIC TARGETSAnnual Review of Pharmacology and Toxicology, 2006
- The Biosynthesis, Fate and Pharmacological Properties of EndocannabinoidsPublished by Springer Science and Business Media LLC ,2005
- Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and SelectivityThe Journal of pharmacology and experimental therapeutics, 2004
- Modulation of anxiety through blockade of anandamide hydrolysisNature Medicine, 2002
- Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolaseProceedings of the National Academy of Sciences of the United States of America, 2001
- Human Platelets and Polymorphonuclear Leukocytes Synthesize Oxygenated Derivatives of Arachidonylethanolamide (Anandamide): Their Affinities for Cannabinoid Receptors and Pathways of InactivationMolecular Pharmacology, 1998